Literature DB >> 16859643

Differential production of leukotriene B4 or prostaglandin E2 by WKYMVm or serum amyloid A via formyl peptide receptor-like 1.

Ha Young Lee1, Seong Ho Jo, Chuhee Lee, Suk-Hwan Baek, Yoe-Sik Bae.   

Abstract

Serum amyloid A (SAA) and Trp-Lys-Tyr-Met-Val-D-Met (WKYMVm) have been reported as formyl peptide receptor-like 1 (FPRL1) ligands. WKYMVm but not SAA stimulated superoxide generation by human neutrophils. In terms of the downstream signalings triggered by WKYMVm and SAA, both agonists stimulated cytosolic phospholipase A2-mediated arachidonic acid release, a precursor of leukotriene B4 (LTB4) and prostaglandin E2 (PGE2). WKYMVm also strongly stimulated LTB4 production in human neutrophils without affecting PGE2 production, whereas SAA strongly stimulates cyclooxygenase-2 (COX-2) expression and PGE2 production but not LTB4 production. In terms of the receptors responsible for the differential actions of these two agonists, we found that FPRL1 is involved in the production of LTB4 by WKYMVm and PGE2 production by SAA. This study demonstrates that the chemoattractant receptor, FPRL1, can be differentially regulated by distinct ligands to generate different lipid mediators, and thus, different immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16859643     DOI: 10.1016/j.bcp.2006.06.022

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

Review 1.  Serum amyloid A: an acute-phase protein involved in tumour pathogenesis.

Authors:  E Malle; S Sodin-Semrl; A Kovacevic
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

2.  LL-37 inhibits serum amyloid A-induced IL-8 production in human neutrophils.

Authors:  Ha Young Lee; Sang Doo Kim; Jae Woong Shim; Sun Young Lee; Jeanho Yun; Yoe-Sik Bae
Journal:  Exp Mol Med       Date:  2009-05-31       Impact factor: 8.718

Review 3.  Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists.

Authors:  Fabio Cattaneo; Melania Parisi; Rosario Ammendola
Journal:  Int J Mol Sci       Date:  2013-04-02       Impact factor: 5.923

4.  A WKYMVm-containing combination elicits potent anti-tumor activity in heterotopic cancer animal model.

Authors:  Sang Doo Kim; Ha Young Lee; Jae Woong Shim; Hak Jung Kim; Suk-Hwan Baek; Brian A Zabel; Yoe-Sik Bae
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

Review 5.  The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.

Authors:  Hui-Qiong He; Richard D Ye
Journal:  Molecules       Date:  2017-03-13       Impact factor: 4.411

6.  A novel antimicrobial peptide acting via formyl peptide receptor 2 shows therapeutic effects against rheumatoid arthritis.

Authors:  Yoo Jung Park; Byunghyun Park; Mingyu Lee; Yu Sun Jeong; Ha Young Lee; Dong Hyun Sohn; Jason Jungsik Song; Joon Ha Lee; Jae Sam Hwang; Yoe-Sik Bae
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

Review 7.  The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview.

Authors:  Marie-Josèphe Rabiet; Emilie Huet; François Boulay
Journal:  Biochimie       Date:  2007-03-03       Impact factor: 4.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.